Michael Midmer

Michael Midmer is a co-founder of Zucara Therapeutics Inc., a company operating in the industry 36 sector. Zucara Therapeutics Inc. headline 36. Based in Toronto, Ontario, Canada, Michael leads the company's strategic vision and day-to-day operations.

Under Michael's leadership, Zucara Therapeutics Inc. recently secured $20M in Series B funding on Nov 1, 2024, backed by investors including Investor 97. This funding milestone reflects strong investor confidence in both the founding team's execution capabilities and the company's market opportunity.

With fresh capital, Michael and the team are focused on scaling operations, expanding the product roadmap, and building out a world-class team. The industry 36 market continues to see significant investment activity, positioning Zucara Therapeutics Inc. to capitalize on growing demand.For vendors and partners, this represents an ideal window to engage.